National Bank of Canada
RCUS icon

National Bank of Canada’s Arcus Biosciences RCUS Stock Holding History

National Bank of Canada’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8K Buy
+91
New +$2.25K ﹤0.01% 2663
2024
Q3 		– Sell
-100
Closed -$1.52K – 2990
2024
Q2 		$1.52K Hold
100
– – ﹤0.01% 2451
2024
Q1 		$1.66K Hold
100
– – ﹤0.01% 2476
2023
Q4 		$1.97K Hold
100
– – ﹤0.01% 2457
2023
Q3 		$1.71K Hold
100
– – ﹤0.01% 2525
2023
Q2 		$2.03K Hold
100
– – ﹤0.01% 2465
2023
Q1 		$1.82K Hold
100
– – ﹤0.01% 2454
2022
Q4 		$2.07K Hold
100
– – ﹤0.01% 2484
2022
Q3 		$3K Hold
100
– – ﹤0.01% 2457
2022
Q2 		$3K Hold
100
– – ﹤0.01% 2553
2022
Q1 		$3K Hold
100
– – ﹤0.01% 2664
2021
Q4 		$4K Buy
+100
New +$3.88K ﹤0.01% 2589

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

National Bank of Canada's RCUS Position: Q2 2026 in Review

National Bank of Canada opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 91 shares worth $2.8K. The stake represents ﹤0.01% of the portfolio and ranks #2663 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in RCUS as recently as Q2 2024.

National Bank of Canada first reported a position in RCUS in Q4 2021 and has held it in 12 quarters since. The position peaked at $4K in Q4 2021. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • National Bank of Canada held 91 shares of Arcus Biosciences worth $2.8K as of Q2 2026.
  • Arcus Biosciences was a new National Bank of Canada position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2663 holding.
  • National Bank of Canada first reported a position in Arcus Biosciences in Q4 2021 and has held it in 12 quarters since.
  • National Bank of Canada's Arcus Biosciences position peaked at $4K in Q4 2021.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.